Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity
Authors:
Open Access
- 1 April 2018
- journal article
- review article
- Published by Wiley in Canadian Journal of Gastroenterology and Hepatology
- Vol. 2018, 1-8
Abstract
Hepatocarcinoma is one of the most prevalent gastroenterological cancers in the world with less effective therapy. As an oncofetal antigen and diagnostic marker for liver cancer, alpha-fetoprotein (AFP) possesses a variety of biological functions. Except for its diagnosis in liver cancer, AFP has become a target for liver cancer immunotherapy. Although the immunogenicity of AFP is weak and it could induce the immune escapes through inhibiting the function of dendritic cells, natural killer cells, and T lymphocytes, AFP has attracted more attention in liver cancer immunotherapy. By in vitro modification, the immunogenicity and immune response of AFP could be enhanced. AFP-modified immune cell vaccine or peptide vaccine has displayed the specific antitumor immunity against AFP-positive tumor cells and laid a better foundation for the immunotherapy of liver cancer.Keywords
Funding Information
- Shaanxi University of Chinese Medicine (2007JK233, 2009xj02, 2010JK484, 14JS025, 15-SCJH001, JCPT001, 2016JM8023, 2016JM8150)
- Education Department of Shaanxi Province (2007JK233, 2009xj02, 2010JK484, 14JS025, 15-SCJH001, JCPT001, 2016JM8023, 2016JM8150)
- Education Department of Shaanxi Province (2007JK233, 2009xj02, 2010JK484, 14JS025, 15-SCJH001, JCPT001, 2016JM8023, 2016JM8150)
- Education Department of Shaanxi Province (2007JK233, 2009xj02, 2010JK484, 14JS025, 15-SCJH001, JCPT001, 2016JM8023, 2016JM8150)
- Education Department of Shaanxi Province (2007JK233, 2009xj02, 2010JK484, 14JS025, 15-SCJH001, JCPT001, 2016JM8023, 2016JM8150)
- Scientific Research Program of Shaanxi Administration of Traditional Chinese Medicine (2007JK233, 2009xj02, 2010JK484, 14JS025, 15-SCJH001, JCPT001, 2016JM8023, 2016JM8150)
- Scientific Research Program of Shaanxi Administration of Traditional Chinese Medicine (2007JK233, 2009xj02, 2010JK484, 14JS025, 15-SCJH001, JCPT001, 2016JM8023, 2016JM8150)
- Natural Science Basic Research Plan in Shaanxi Province of China (2007JK233, 2009xj02, 2010JK484, 14JS025, 15-SCJH001, JCPT001, 2016JM8023, 2016JM8150)
- Natural Science Basic Research Plan in Shaanxi Province of China (2007JK233, 2009xj02, 2010JK484, 14JS025, 15-SCJH001, JCPT001, 2016JM8023, 2016JM8150)
This publication has 77 references indexed in Scilit:
- Glycoprotein 96 and α-Fetoprotein Cross-Linking Complexes Elicited Specific Antitumor ImmunityCancer Biotherapy and Radiopharmaceuticals, 2013
- Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinomaInternational Journal of Oncology, 2012
- Downregulation of alpha-fetoprotein expression by LHX4: a critical role in hepatocarcinogenesisCarcinogenesis, 2011
- α-Fetoprotein impairs activation of natural killer cells by inhibiting the function of dendritic cellsClinical and Experimental Immunology, 2011
- Liver cancer epidemic in China: Past, present and futureSeminars in Cancer Biology, 2011
- Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinomaWorld Journal of Gastroenterology, 2011
- Dendritic Cell-Based Vaccines Positively Impact Natural Killer and Regulatory T Cells in Hepatocellular Carcinoma PatientsJournal of Immunology Research, 2011
- Prolonged recurrence-free survival following OK432-stimulated dendritic cell transfer into hepatocellular carcinoma during transarterial embolizationClinical and Experimental Immunology, 2010
- Biological activity of truncated C-terminus human heat shock protein 72Immunology Letters, 2010
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous MalignancyImmunity, 2008